Revvity, Inc. (RVTY) is a publicly traded Healthcare sector company. As of September 1, 2026, RVTY trades at $128.57 with a market cap of $14.37B and a P/E ratio of 62.22. RVTY moved -0.18% today. Year to date, RVTY is +33.13%; over the trailing twelve months it is +44.35%. Its 52-week range spans $81.22 to $130.07. Analyst consensus is buy with an average price target of $116.57. Rallies surfaces RVTY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Revvity, Inc. (RVTY) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RVTY moved -0.18% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $128.57 |
| Market Cap | $14.37B |
| P/E Ratio | 62.22 |
| EPS | $2.07 |
| Dividend Yield | 0.07% |
| 52-Week High | $130.07 |
| 52-Week Low | $81.22 |
| Volume | 72 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.86B |
| Net Income | $241.20M |
| Gross Margin | 0.00% |
9 analysts cover RVTY: 0 strong buy, 3 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $116.57.